State of the world's vaccines and immunization.

Format
Book
Language
English
Εdition
Rev. ed. 2003.
Published/​Created
[Geneva] : World Health Organization, 2003.
Description
116 p.

Details

Subject(s)
Related name
Summary note
This latest edition of State of the World's Vaccines and Immunization highlights the immense progress made in global immunization since the mid-1990s. These achievements include the near-eradication of polio worldwide as well as dramatic reductions in the incidence of measles and maternal and neonatal tetanus in some of the lowest-income countries. This report also charts progress in the development and introduction of new life-saving vaccines that have the potential to save millions of lives each year. However, the report also points out that many children have yet to benefit from these achievements. In Sub-Saharan Africa, for example, only about 50% of children are immunized during their first year of life. The report highlights obstacles to equitable world-wide access to effective and safe immunization and how these can be overcome.
Notes
Bibliographic Level Mode of Issuance: Monograph
Language note
English
Contents
  • Cover
  • Acknowledgements
  • Contents
  • Acronyms
  • Foreword
  • Call to action
  • Executive summary
  • Figure 1: Children not immunized (DTP3), 2001
  • Part 1: Immunization challenges
  • 1. Coverage gaps
  • Figure 2: Immunization coverage, 1980-2001, 3 doses DTP - global and by region
  • 2. Health service delivery gaps
  • 3. Gaps in access to new vaccines
  • Figure 3: Number of childhood vaccines routinely used in developing and established market countries
  • 4. R&
  • D gaps
  • Figure 4: Average vaccine development costs per product
  • 5. Immunization safety gaps
  • Vaccine quality and safety
  • Injection safety
  • 6. Finance gaps
  • Figure 5: Cost profile of immunization programmes
  • Part 2: Charting a way forward
  • 1. The power of partnership: GAVI
  • New ways of working
  • Achieving the common targets
  • Figure 6: GAVI-Vaccine Fund support
  • 2. Development and introduction of new vaccines
  • Guaranteeing a market
  • Figure 7: Immunization - from research to disease prevention
  • Clinical trials
  • Tiered pricing
  • Recent trends in the vaccine market
  • Figure 8: Manufacturers leaving the development country market, 1992-2001
  • 3. Improving immunization services
  • Capacity building support
  • Immunization as a platform for other health services
  • Reaching the unreached
  • Harnessing new technology
  • New initiatives on immunization safety
  • Assuring vaccine quality and safety
  • Figure 9: Status of national regulatory authorities (NRAs) June 2002
  • Safer injections
  • 4. Financing vaccines and immunization
  • Mobilizing increased financing of immunization
  • Figure 10: Variability in sources of financing of immunization programmes for selected countries
  • National funding commitments
  • New financing mechanisms
  • Part 3: Vaccines update
  • 1. Underused vaccines
  • Haemophilus influenzae type b
  • Hepatitis B.
  • Figure 11: Number of countries introduced HepB vaccine and global HepB3 coverage, 1989-2001
  • Yellow fever
  • Rubella (German measles)
  • 2. Eradication or elimination of vaccine-preventable diseases
  • Figure 12: Polio - the last child
  • Polio
  • Measles
  • Figure 13: Reported measles cases and coverage with MCV - Eastern European Region 1971-2000
  • Figure 14: Maternal and neonatal tetanus elimination status as of July 2002
  • Maternal and neonatal tetanus
  • 3. Priority new vaccines
  • HIV/AIDS
  • Malaria
  • Tuberculosis (TB)
  • Pneumococcal disease (Streptococcus pneumoniae)
  • Meningococcal meningitis
  • Rotavirus diarrhoea
  • 4. Neglected vaccines
  • Shigella dysentery
  • Dengue
  • Japanese encephalitis
  • Leishmaniasis
  • Schistosomiasis
  • Cholera
  • 5. Other vaccines
  • Cervical cancer (HPV)
  • Respiratory syncytial virus (RSV)
  • Herpes simplex virus type 2
  • Enterotoxigenic Escherichia coli (ETEC)
  • Part 4: Conclusion
  • Investing in immunization
  • Towards a brighter future
  • Annex 1: Prequalified vaccines
  • Annex 2: Glossary of vaccine terms
  • Annex 3
  • A national immunization schedule for infants in developing countries
  • A national immunization schedule for infants in industrial countries
  • Annex 4: Statistical annex
  • Photo credits.
ISBN
  • 1-280-06062-X
  • 9786610060627
  • 92-4-068134-5
OCLC
437176297
Statement on language in description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage. Read more...
Other views
Staff view